{
    "Trade/Device Name(s)": [
        "ARCHITECT Digoxin Immunoassay",
        "ARCHITECT Digoxin Reagents",
        "ARCHITECT Digoxin Calibrators",
        "ARCHITECT iDigoxin Assay",
        "ARCHITECT iDigoxin Calibrator"
    ],
    "Submitter Information": "Biokit S.A.",
    "510(k) Number": "K082953",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023058"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KXT",
        "DLJ"
    ],
    "Summary Letter Date": "December 22, 2008",
    "Summary Letter Received Date": "October 6, 2008",
    "Submission Date": "September 30, 2008",
    "Regulation Number(s)": [
        "21CFR862.3320",
        "21CFR862.3200"
    ],
    "Regulation Name(s)": [
        "Digoxin Test System",
        "Calibrator, drug specific"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Digoxin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT Digoxin Immunoassay and Calibrators for quantitative measurement of digoxin in serum or plasma using CMIA technology",
    "Indications for Use Summary": "Quantitative measurement of digoxin in human serum or plasma to aid in diagnosis and treatment of digoxin overdose and in monitoring therapy; calibrators are for calibration of the ARCHITECT i System for digoxin determination",
    "fda_folder": "Toxicology"
}